Active filters: Keyword · All time

Results for " free days " · 1 found 🔀 AI-powered Shuffle

Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial

Jun 28 • 3:45 PM EDT • Health • astrazeneca-us.com

Read story